Valuation: SI-BONE, Inc.

Market Cap 741M 652M 605M 557M 1.04B 71.77B 1.06B 7.24B 2.82B 35B 2.78B 2.72B 121B P/E 2026 *
-38.4x
P/E 2027 * -46.1x
Enterprise Value 741M 652M 605M 557M 1.04B 71.77B 1.06B 7.24B 2.82B 35B 2.78B 2.72B 121B EV / Sales 2026 *
3.2x
EV / Sales 2027 * 2.78x
Free-Float
96.58%
Yield 2026 *
-
Yield 2027 * -
1 week-2.00%
Current month+3.52%
1 month+6.52%
3 months+23.53%
6 months+1.38%
Current year-13.53%
1 week 14.4
Extreme 14.4
15.8
1 month 13.8
Extreme 13.8
15.9
3 years 9.85
Extreme 9.85
23.4
5 years 9.85
Extreme 9.85
26.8
Manager TitleAgeSince
Chief Executive Officer 59 2021-04-19
Director of Finance/CFO 46 2021-04-18
Chief Tech/Sci/R&D Officer 64 2017-01-31
Director TitleAgeSince
Chairman 71 2008-03-17
Director/Board Member 72 2012-12-31
Director/Board Member 56 2008-03-17
Change 5-day change 1-year change 3-year change Capi.($)
-2.04%-2.00%+0.68%-34.96% 741M
+0.44%+0.37%+37.10%+4.72% 12.45B
-1.76%+10.89%+21.35%+19.35% 6.55B
-0.53%-1.99%+51.79%+21.11% 5.56B
0.00%+5.90% - - 4.59B
+2.14%+0.83%-27.36%+22.99% 4.38B
-1.76%-0.33%-22.06%-21.97% 4.11B
+28.39%+24.70%+22.64%-48.64% 1.8B
0.00%-6.35%-13.24%+219.26% 1.73B
+0.33%-0.33%+60.10%-3.17% 1.55B
Average +3.03%+1.44%+14.56%+19.85% 4.75B
Weighted average by Cap. +1.05%+2.57%+20.34%+14.74%

Financials

2026 *2027 *
Net sales 232M 204M 189M 174M 326M 22.43B 332M 2.26B 883M 10.94B 870M 851M 37.96B 267M 235M 218M 200M 376M 25.82B 382M 2.61B 1.02B 12.59B 1B 979M 43.69B
Net income -19.59M -17.23M -16.01M -14.72M -27.61M -1.9B -28.1M -191M -74.66M -925M -73.55M -71.96M -3.21B -16.77M -14.75M -13.7M -12.6M -23.63M -1.62B -24.06M -164M -63.91M -792M -62.96M -61.6M -2.75B
Net Debt - -
Logo SI-BONE, Inc.
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
Employees
-
Date Price Change
26-07-23 14.40 -2.04%
26-07-22 €14.70 -2.00%
26-07-21 €15.00 0.00%
26-07-20 €15.00 -0.66%
26-07-17 €15.10 -2.58%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
16.71USD
Average target price
24.50USD
Spread / Average Target
+46.62%

Quarterly revenue - Rate of surprise